IPO in the era of COVID-19
- By : Wong Mei Ying
- Category : Equity capital markets (ECM), IPO, Linkedin Post
Companies which intend to undertake IPO during the COVID-19 pandemic may need to disclose the impact of COVID-19 on their business and operations in prospectus.
Some of the additional disclosure in prospectus during the COVID-19 pandemic may include:
– whether the pandemic and the movement control order (MCO) imposed by the government have caused delay to their supply of goods or services
– whether the companies are in breach of any of their contractual obligations due to the pandemic and the MCO
– whether the pandemic and the MCO have adverse financial impact on the companies
– the companies’ contingency plan in dealing with the impact of COVID-19
As with any other information in prospectus, the companies must ensure the above information, if disclosed in prospectus, must be true, not misleading and does not contain any material omission.
#malaysiancorporatelawyer
#malaysianIPO
#IPO
#howtoIPO
This post was first posted on Linkedin on 18 February 2021.
